Is multiple myeloma cancer?

Multiple myeloma may sound unfamiliar, but it is indeed a type of cancer. It does not originate from epithelial tissue as we often call it, but originates from plasma cells in the bone marrow, so it is classified as a hematological malignancy. Simply put, multiple myeloma is a disease caused by the malignant proliferation of plasma cells.

These malignant plasma cells not only proliferate disorderly in the bone marrow, but also produce abnormal immunoglobulin, namely M protein, which leads to a series of clinical symptoms. Anemia, bone pain, renal insufficiency, hypercalcemia, etc. are all sufferings that patients with multiple myeloma may face. What's more serious is that these malignant cells may also transfer to other tissues and organs, causing more extensive damage.

In terms of age of onset, multiple myeloma is more likely to occur in middle-aged and elderly people, especially in people aged 50-60 years. The incidence rate in men is slightly higher than in women. Although the exact cause of multiple myeloma is not yet fully understood by the medical community, it has been confirmed that it is not caused by a single factor, but is the result of a combination of internal and external factors.

Multiple myeloma is different from many solid tumors when it comes to treatment. Since it primarily affects the blood system, surgical treatment is not the first choice. On the contrary, chemotherapy, radiotherapy and immunotherapy, which have emerged in recent years, play a more important role in the treatment of multiple myeloma. However, despite the continuous advancement of treatments, multiple myeloma is still a disease that is difficult to completely cure, and patients' survival and quality of life are seriously affected.

To sum up, multiple myeloma is undoubtedly a kind of cancer, which brings huge challenges to the medical community and patients with its unique pathogenesis and clinical manifestations. However, with the deepening of scientific research and the advancement of medical technology, we believe that there will be more effective ways to deal with this problem in the future.

(Common multiple myeloma treatment drugs include: melphalan, melphalan, bortezomib, ixazomib, etc. For specific drug details, please see the website homepage or click for consultation.)